biotech / news / / Los Angeles Times
Northridge-based MiniMed Group Inc. began trading on March 6 as a split-off from Medtronic.
MiniMed Group split from Medtronic, began trading as MMED, and authorized a $100M stock repurchase.
KEY POINTS
- Novartis acquired San Diego-based Avidity Biosciences for $12 billion after successful clinical trial results.
- AnaptysBio will spin off its biopharma portfolio into a new public company, First Tracks Biotherapeutics, by 2026.
- Amgen plans over $600 million investment in a new science and innovation center at Thousand Oaks headquarters.
COMPANIES
Summarized by Newsio from Los Angeles Times. How we summarize →